Charlene G La Frenz is a Bemidji, Minnesota based nurse practitioner. Active license number of Charlene G La Frenz is R154863-9 in Minnesota. Her current practice location is 1100 38th St Nw, Bemidji. Patients can reach her at 218-751-5430 or can fax her at 218-759-5880. Charlene G La Frenz is NP and her NPI number (Unique professional ID assigned by NPPES) is 1538338603. Charlene G La Frenz has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Charlene G La Frenz speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1538338603
NPI Enumeration Date:
22 Feb, 2008
NPI Last Update On:
02 Nov, 2010
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Charlene G La Frenz are as mentioned below.
License Number
Specialization
State
Status
R154863-9
Minnesota
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Charlene G La Frenz 2210 Fox Dr Nw, Bemidji, Minnesota
Zip:
56601-9242
Phone Number:
218-333-0882
Patients can reach Charlene G La Frenz at 1100 38th St Nw, Bemidji, Minnesota or can call to book an appointment on 218-751-5430.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.